InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
vinmantoo Free
02/26/20 10:58 PM
profile icon
MegaDeath PremiumMember
02/24/20 2:17 PM
profile icon
vinmantoo Free
02/24/20 2:14 PM
profile icon
MegaDeath PremiumMember
02/21/20 12:00 PM
profile icon
vinmantoo Free
02/21/20 11:58 AM
profile icon
ClayTrader Free
02/20/20 6:09 PM
profile icon
MegaDeath PremiumMember
02/20/20 12:41 PM
profile icon
vinmantoo Free
02/20/20 12:33 PM
profile icon
MegaDeath PremiumMember
02/20/20 11:39 AM
profile icon
ClayTrader Free
12/23/19 5:00 PM
profile icon
vinmantoo Free
11/04/19 4:46 PM
profile icon
vinmantoo Free
10/28/19 1:04 PM
profile icon
vinmantoo Free
10/23/19 6:32 PM
profile icon
vinmantoo Free
10/10/19 3:06 PM
profile icon
ClayTrader Free
10/02/19 5:31 PM
profile icon
whytestocks Free
10/02/19 4:50 PM
profile icon
whytestocks Free
10/02/19 4:40 PM
profile icon
whytestocks Free
10/02/19 4:30 PM
profile icon
whytestocks Free
10/02/19 4:24 PM
profile icon
vinmantoo Free
10/02/19 12:53 PM
profile icon
MegaDeath PremiumMember
10/02/19 8:06 AM
profile icon
MegaDeath PremiumMember
10/02/19 7:48 AM
profile icon
ClayTrader Free
08/21/19 7:21 PM
profile icon
whytestocks Free
06/28/19 3:10 PM
profile icon
whytestocks Free
06/28/19 3:00 PM
profile icon
whytestocks Free
06/28/19 2:50 PM
profile icon
vinmantoo Free
06/18/19 12:16 PM
profile icon
whytestocks Free
06/17/19 4:40 PM
profile icon
Zilla Free
05/24/19 1:16 AM
profile icon
saturnz Free
05/06/19 9:11 PM
profile icon
saturnz Free
04/24/19 3:06 PM
profile icon
saturnz Free
04/22/19 1:04 PM
profile icon
Bored Lawyer Free
02/07/19 10:41 PM
profile icon
vinmantoo Free
11/09/18 12:05 AM
profile icon
vinmantoo Free
11/09/18 12:05 AM
profile icon
Zilla Free
11/08/18 3:17 PM
profile icon
vinmantoo Free
10/14/18 6:23 PM
profile icon
finesand Free
10/14/18 3:50 PM
profile icon
vinmantoo Free
10/14/18 1:28 PM
profile icon
Zilla Free
10/14/18 12:55 AM

Progenics Pharmaceuticals Inc. (PGNX) RSS Feed

Followers
59
Posters
124
Posts (Today)
0
Posts (Total)
796
Created
03/12/08
Type
Free
Moderators

http://www.progenics.com/

http://finance.yahoo.com/q/ks?s=PGNX

Progenics Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products for the treatment of unmet medical needs of patients with debilitating conditions and life-threatening diseases in the United States. It primarily focuses on the areas of gastroenterology, virology, and oncology. The company's development programs and product candidates include methylnaltrexone-subcutaneous, which completed Phase 3 clinical trial for the treatment of opioid-induced constipation; methylnaltrexone-intravenous, which is under Phase 3 clinical trial for the management of post-operative ileus; and Methylnaltrexone-Oral, a Phase 2 clinical trial oral form for the treatment of opioid-induced constipation. It is also developing PRO 140 Phase 1b clinical trial, designed to block HIV infection by inhibiting virus-cell binding; ProVax, a vaccine product candidate for the prevention of HIV infection or therapeutic treatment for HIV-positive individuals; and GMK Vaccine, a therapeutic vaccine, which is in Phase 3 clinical trial for the prevention of recurrence of melanoma. In addition, the company engages in a research program to discover treatments for hepatitis C, a chronic liver disease that block viral entry into cells. Further, Progenics Pharmaceuticals, through a joint venture with Cytogen Corporation, is developing in vivo immuno-therapies for treatment of prostate cancer, including a human monoclonal antibody-drug conjugate directed against prostate-specific membrane antigen (PSMA). The company's PSMA vaccine is in Phase 1 clinical testing. It has a collaboration agreement with Wyeth Pharmaceuticals to develop and commercialize subcutaneous, intravenous, and oral forms of methylnaltrexone. The company was incorporated in 1986 and is based in Tarrytown, New York.





 

Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
PGNX Latest News
  • No Recent News Available for this company!
New Post